AI in Healthcare Market Size Set to Reach USD 305.96 Billion by 2033 | As Medical Imaging, Generative AI, Drug Discovery and Clinical Automation Drive 30.1% CAGR

According to DataM Intelligence, The AI in Healthcare Market reached US$ 35.96 billion in 2025 and is expected to reach US$ 305.96 billion by 2033, growing at a CAGR of 30.1% during 2026-2033. The market is being driven by increasing healthcare data volumes, rising demand for faster and more accurate diagnosis, chronic disease management, clinical workflow automation, personalized medicine and AI-enabled drug discovery.

Medical imaging, predictive analytics, virtual assistants, precision medicine and remote patient monitoring are creating expanding commercial applications for AI across healthcare providers, payers, pharmaceutical companies and biotechnology organizations.

Download Sample Report (Get Higher Priority for Corporate Email ID):-
https://www.datamintelligence.com/download-sample/ai-in-healthcare-market?chh

Recent 2026 Industry Developments

September 2026 - FDA AI-enabled medical device authorizations continue expanding:

The U.S. FDA's current database shows more than 1,600 AI-enabled medical devices authorized for marketing in the United States as of September 2026. Recent authorizations span radiology, cardiovascular care, neurology, pathology, ultrasound and other clinical applications, demonstrating the continued movement of healthcare AI from research environments into regulated medical products.

August 2026 - FDA advances regulatory discussion for generative AI medical devices:

The FDA issued a discussion paper seeking public input on regulatory considerations for generative-AI-enabled medical devices, including risk assessment, premarket evaluation and postmarket monitoring. The development highlights the growing importance of validation, safety and lifecycle oversight as generative AI enters clinical applications.

July 2026 - U.S. launches Bio Genesis Mission:

HHS and NIH announced the Bio Genesis Mission, using AI, advanced computing and biomedical datasets to accelerate chronic-disease research, pediatric cancer research and drug discovery. NIH stated that more than US$1.2 billion in FY2026 obligated and planned FY2027 funding was aligned with related challenge areas.

June 2026 - NIH opens PRIMED-AI funding opportunities:

NIH introduced the PRIMED-AI program to develop AI tools integrating medical imaging with other clinical data for precision medicine. The program includes validation, multimodal AI frameworks, academic-industry partnerships and pathways for moving AI tools from prototypes toward clinical applications.

March 2026 - Roche expands AI infrastructure:

Roche announced an AI factory with an additional 2,176 NVIDIA Blackwell GPUs, taking its combined on-premise and cloud infrastructure to more than 3,500 GPUs. The infrastructure is being applied across drug discovery, diagnostics, digital pathology, manufacturing and clinical development.

Find the Right Partners Today:
https://www.datamintelligence.com/partner-identification-enquiry/ai-in-healthcare-market?chh

Strategic Growth Landscape: M&A, Technology Innovation, Investment and Regulatory Readiness

Healthcare AI is increasingly shifting from isolated pilots toward integrated platforms spanning diagnosis, clinical decision support, drug discovery, administrative automation and patient engagement. NVIDIA's 2026 healthcare survey reported that 70% of respondents were actively using AI, while 69% were using generative AI or large language models and 47% were using or assessing agentic AI. The survey also found that 85% expected healthcare AI budgets to increase in 2026.

The investment landscape is expanding beyond software applications into AI infrastructure, specialized models, medical imaging, digital pathology and computational drug discovery. NVIDIA-Lilly's US$1 billion co-innovation initiative and Roche's expansion to more than 3,500 GPUs demonstrate the increasing capital intensity of healthcare AI infrastructure.

In the United States, government-backed AI and biomedical initiatives are adding another layer of demand. The Bio Genesis Mission and PRIMED-AI program are emphasizing AI-enabled biomedical discovery, multimodal clinical data, validation and translation into clinical applications.

In Japan, healthcare AI growth is increasingly connected to broader medical digitalization. Japan's Ministry of Health, Labour and Welfare continued work in 2026 on healthcare DX, electronic medical-record information sharing, standardized systems and healthcare-data utilization, creating infrastructure relevant to future AI deployment.

Get 20% Complimentary Customization Within the Report:
https://www.datamintelligence.com/customize/ai-in-healthcare-market?chh

Key Players and Strategic Positioning

NVIDIA Corporation

NVIDIA is positioning itself as an infrastructure and software provider for healthcare AI rather than only a semiconductor supplier. Its healthcare ecosystem spans accelerated computing, biomedical foundation models, drug discovery, medical imaging and AI factories. The NVIDIA - Lilly collaboration and Roche AI factory demonstrate how GPU infrastructure is becoming embedded in pharmaceutical R&D and healthcare workflows.

Microsoft

Microsoft is expanding healthcare AI through cloud infrastructure, clinical data platforms, AI models and research initiatives. Its 2026 Health Futures research portfolio includes multimodal medical AI, healthcare-agent benchmarks, medical foundation-model research and evaluation of frontier AI models for healthcare applications.

Siemens Healthineers

Siemens Healthineers is integrating AI across medical imaging, diagnostics, procedure automation and digital healthcare. Its healthcare AI platform includes AI-powered clinical solutions and operational-twin concepts designed to support workflow optimization, resource allocation and personalized treatment.

The company reports more than 2.3 billion curated images, reports and clinical/genomic data within its Big Data Office and more than 1,800 daily AI experiments on its Sherlock supercomputer.

Purchase This Exclusive Report:
https://www.datamintelligence.com/buy-now-page?report=ai-in-healthcare-market?chh

Additional Benifits:
✅ Get Interactive Dashboard Access (With No Additional Coast)
✅ Three months of analyst support to answer queries related to the report.

AI in Healthcare Market Segmentation Analysis

By Component Type

The market is segmented into software, services and hardware. Software represents the largest component, supported by AI diagnostic platforms, clinical decision-support systems, predictive analytics, NLP applications and healthcare automation. DataM Intelligence estimates software at approximately 60.5% of the market.

By Technology

Key technologies include machine learning, natural language processing, speech recognition and other AI technologies. Machine learning remains central to medical imaging, risk prediction and clinical analytics, while NLP and speech technologies are expanding through clinical documentation, virtual assistants and medical information retrieval.

By Application

Applications include medical imaging and diagnostics, precision medicine, drug discovery and development, virtual assistants, lifestyle management and monitoring, healthcare assistant robots, insights and risk analytics, and other applications. Medical imaging and diagnostics remain important adoption areas, while drug discovery and generative AI are expanding the addressable opportunity.

Regional Analysis

United States

The United States remains a major AI healthcare investment and commercialization hub. FDA-authorized AI-enabled medical devices now exceed 1,600, covering applications across imaging, cardiology, neurology and other specialties. Government programs including Bio Genesis and PRIMED-AI are also expanding the role of AI in biomedical research, multimodal clinical data and precision medicine.

Japan

Japan's opportunity is closely linked to healthcare digital transformation, electronic health-record interoperability and the utilization of medical information. MHLW continued healthcare-DX initiatives during 2026, including electronic medical-record information sharing and standardized healthcare systems. These infrastructure developments can support broader deployment of clinical analytics and AI-enabled healthcare services.

Germany

Germany combines a strong medical-technology industry with growing healthcare digitization and AI research. Companies such as Siemens Healthineers are integrating AI into imaging, diagnostics, procedure automation and hospital operations. The country's advanced healthcare infrastructure and medical-device ecosystem provide opportunities for validated AI applications with strong workflow integration and regulatory compliance.

South Korea

South Korea is developing a strong healthcare-AI ecosystem around medical imaging, digital pathology and precision oncology. Lunit's 2026 public-health deployment and cancer research activities illustrate how AI is moving from diagnostic assistance toward biomarker analysis and treatment-response research. Government-supported AI healthcare programs are also supporting adoption outside major metropolitan hospitals.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us

DataM Intelligence is a market research and consulting firm that delivers comprehensive end-to-end business solutions, covering everything from in-depth research to strategic consulting. The company leverages key industry trends, insights, and developments to provide fast, reliable, and actionable solutions tailored to diverse client requirements.

It offers both syndicated and customized research reports supported by a strong and robust methodology. With an extensive database comprising 9000+ reports across 40+ industry domains, DataM Intelligence serves over 200 companies in more than 50 countries, helping organizations access critical business intelligence that drives informed decision-making and sustainable growth.

This release was published on openPR.